CVX vs ISRG: Which Is the Better Buy?
Side-by-side comparison of Chevron Corporation and Intuitive Surgical, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-16.
Chevron Corporation · Energy
$175.91
-3.4% upside to fair value
Grade D
VS
Intuitive Surgical, Inc. · Healthcare
$388.97
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
ISRG has more upside to fair value
(+45.0%).
CVX trades at a lower forward P/E
(30.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CVX |
ISRG |
| Current Price |
$175.91 |
$388.97 |
| Fair Value Estimate |
$169.96 |
$564.01 |
| Upside to Fair Value |
-3.4%
|
+45.0%
|
| Market Cap |
$350.3B |
$137.8B |
| Forward P/E |
30.4x
|
46.5x
|
| EV / EBITDA |
9.4x
|
31.4x
|
| Price / Sales |
1.9x
|
13.0x
|
| Price / FCF |
26.2x
|
48.6x
|
| Revenue Growth YoY |
+3.2%
|
+23.0%
|
| Gross Margin |
25.4%
|
66.3%
|
| Operating Margin |
8.4%
|
30.5%
|
| Return on Equity |
6.2%
|
17.0%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.82%
|
2.06%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Chevron Corporation operates as a leading integrated oil and gas company within the energy sector, demonstrating medium business quality with a stable competitive position but facing earnings pressure as evidenced by a 36.9% decline in earnings in the most recent quarter. The stock trades at a premium valuation with a P/E trailing and forward of 30.38, EV/EBITDA of 9.41, and a P/FCF of 26.2, refl…
Intuitive Surgical, Inc. operates in the healthcare sector, specializing in medical devices with a strong focus on robotic-assisted surgery systems. The company demonstrates high business quality with a durable competitive moat supported by a 17.0% return on equity, robust gross margin of 66.3%, and solid operating margin of 30.5%. Revenue and earnings growth in the most recent quarter were impre…
Accumulation Zones
| Metric |
CVX |
ISRG |
| Zone Low |
$127.47 |
$423.01 |
| Zone High |
$144.47 |
$479.41 |
| In Buy Zone? |
No
|
Yes
|